Phathom Pharmaceuticals(PHAT) - 2025 Q4 - Annual Results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 7, 2026 PHATHOM PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) Delaware 001-39094 82-4151574 (State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification No.) 100 Campus Drive, Suite 102 Florham Par ...